Clinical Trial

A Novel Method for Determination of Thromboembolic Stroke Origin

Not Yet Recruiting Early Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated May 8, 2025 (before its estimated June 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
Rupture of vulnerable carotid, vertebral, and intracranial arterial plaques results in thromboembolic stroke. Identification of these culprit lesions is an important component of post-stroke care. This study seeks to test the feasibility of NaF PET-CT to detect these plaques and alter patient care. Prior studies have shown a high degree of correlation between NaF PET+ lesions and high-risk plaque features on high resolution MRI, including mirocalcification, necrosis, and ulceration.
Trial Details
NCT Number NCT06961604
Lead Sponsor Atlantic Health System
Conditions Thromboembolic Stroke
Enrollment 20 participants
Start Date 2025-06-01
Primary Completion 2025-06-01 (estimated)
Study Completion 2026-05-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-08